Endometriosis Trial, Recruiting NCT06153303 Sponsor: Skane University Hospital Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT06153303
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have a confirmed diagnosis of endometriosis
  • You are between 18 and 65 years old
  • You have had a full medical check-up and received any recommended medical treatment
  • You are able to actively take part in a rehabilitation programme and commit to around 5 hours of treatment activities per week
  • You are on a stable, unchanged dose of any medication you take
  • You are able to read and write in Swedish
  • You have access to a smartphone or computer with an internet connection

Who may not be able to join:

  • You have a serious or acute mental health condition that is considered the main health concern, such as untreated bipolar disorder, OCD, psychosis, severe depression, PTSD, or ongoing substance dependence
  • You are currently misusing painkillers (including strong prescription painkillers), alcohol, or other drugs
  • You have significant difficulty managing intense emotions in ways that could lead to emotional outbursts or self-harm
  • You have a health condition that creates medical risks that would affect participation (confirm with trial site)
  • You are facing serious social or financial difficulties, or have limited support around you, that would make it hard to make lifestyle or behaviour changes
  • You are currently experiencing severe thoughts of suicide that require immediate professional intervention

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 004646171520

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Skane University Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
1 October 2026

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Pain interference as measured by the Multidimensional Pain Inventory (MPI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov